ANIMAL HEALTH NEWS-MARCH

Late March 2024, the veterinary and animal health industry witnessed significant events, including major international fairs like Iberzoo+Propet and Global Pet Expo, product launches by companies like Acana Pet Food and Biogénesis Bagó, financial announcements from companies like Vetoquinol and Virbac, partnerships such as Farmsee Ltd with Merck Animal Health, and advancements in technology showcased by companies like Tecnofarm and BU Aqua with Vaxxinova Autogenous Vaccines GmbH, all contributing to the continuous growth and innovation within the sector.

?

?? Iberzoo+Propet 2024,?The international fair for pet professionals, organized by IFEMA Madrid and promoted by the Madrid Association of Companion Animal Veterinarians (AMVAC) and the Spanish Association of the Pet Industry and Commerce Sector (Aedpac), concluded its latest edition. This event, a key gathering for pet professionals, brought together over 220 companies in nutrition, veterinary medicine, and technology from March 13th to 15th, showcasing their latest innovations and products to thousands of veterinarians. (diarioveterinario.com, March 15th.).

?? Global Pet Expo thook place March 20-22, 2024 at the Orange County Convention Center in Orlando, Fla. Presented by the American Pet Products Association (APPA) and Pet Industry Distributors Association (PIDA), the expo is the pet industry's premier event featuring the newest, most innovative pet products on the market today. (globalpetexpo.org, March).

?? Acana Pet Food, Introducing their new products at Iberzoo+Propet 2024, the company's cat recipes have taken center stage. The brand has revamped the design and enhanced the formulation of Premium Cat and Highest Protein, and has also introduced Kitten for kittens. All of these will be available in Spain and Portugal soon. (portalveterinaria.com, March 21th).

?? ISRAEL???Farmsee?Ltd announced that?Merck Animal Health?has participated in FarmSee's A round and has entered into a long-term agreement to integrate FarmSee's AI-based weighing technology into its global offerings for swine producers.?Munters?also participated in the A round fund.?(prnewswire).

?? Livisto showcased their latest innovations at the Iberzoo+Propet 2024 fair. For the third consecutive year, the entire sales team was present to introduce the recent launches of 2024. On one hand, they introduced the new dermatology line, V-SKIN, designed by European diplomate Mar Bardagí. Additionally, they unveiled their new cardiology product, Cardisan, a generic with pimobendan as the active ingredient, with a rock-themed presentation by The Cardisans. Moreover, they took advantage of the event to pre-launch Artennua XL, a new format for large breeds featuring optimized Artemisia annua, a novelty that was presented by Luís Matías in a talk at the Veterinary Classroom attended by over 30 people. (animalshealth.es, March 20th).

?? The FDA announced it has approved?Dechra's DuOtic (terbinafine and betamethasone acetate otic gel) for the treatment of otitis externa in dogs, associated with susceptible strains of yeast (Malassezia pachydermatis). DuOtic is the first FDA-approved animal drug intended to treat yeast-only otitis externa in dogs.?(FDA).

?? Phibro Animal Health Corp. announced it is expanding its manufacturing facility to support Animate, a patented anionic mineral supplement for pre-partum dairy cattle, which may help to reduce the incidence of clinical and subclinical hypocalcemia.?(Feed Strategy).

?? Amazon?reported results for the full year 2023. U.S. pet product sales were $18.2 billion, up 25% from the prior year. Amazon's private label brand of pet supplies were $207 million, up 43%.?(Globalpets).

?? Virbac?have presented their financial results for 2023, a period in which the current operating profit (before depreciation of acquisition-related assets) amounted to 188.1 million euros, nearly 1% higher than the previous year. The consolidated net profit was 121.1 million euros, remaining stable compared to the same period in 2022, while the net profit attributable to the group's share amounted to 121.3 million euros in 2023, also stable compared to the previous year (121.9 million euros). This result was driven by an estimated price increase of around 5%, coupled with a more favorable product mix. This organic growth led to an increase in gross margin in absolute value. (animalshealth.es, March 19th).

?? MSD Saud Animal: As part of its participation in the Iberzoo+Propet 2024 fair, MSD Animal Health will once again be the main sponsor at Vetmadrid, the 41st Congress of AMVAC on "Medicine and Surgery of the Digestive System and Nutrition," which took place from March 13th to 15th, reinforcing its strong commitment to the veterinary community. As part of the congress program, MSD Animal Health organized a symposium on the morning of Thursday, March 14th, titled "The Time Revolution: Unveiling the Future of Antiparasitics," which interested veterinarians could attend for free at Vetmadrid. (portalveterinaria.com, March 11th).

?? Biogénesis Bagó has launched Biopoligen Q, a combined vaccine to combat livestock diseases. The new Biopoligen Q, a combination vaccine of inactivated strains to combat key diseases in livestock, has been introduced by Biogénesis Bagó. This product is designed to prevent and treat one of the main conditions in feedlots, such as bovine respiratory syndrome. The launch of Biopoligen Q is part of Biogénesis Bagó's campaign called "Mission Possible," which aims to achieve maximum profitability by maximizing the number of calves through the implementation of preventive health plans at each stage of breeding. (minutodecierre.com, March 13th).

?? Tecnofarm Argentina, the veterinary laboratory, has recertified its GMP standards. With a focus on continuous improvement, the veterinary laboratory is advancing its lines for bovines and equines while also promoting manufacturing for third parties under GMP standards. Tecnofarm operates within a facility of 1,000 square meters for production areas and a warehouse for finished products of another 400 square meters. It employs 27 staff members and has a robust planning system that allows it to serve over 10 third-party laboratories and more than 250 own clients. Top of Form. (motivar.com.ar, March).

?? Richmond Vet Pharma Richmond Vet Pharma celebrates its 27th anniversary in the veterinary industry. With over 100 registered veterinary products, a presence in 30 countries, and a series of milestones in innovations, the veterinary laboratory marks this occasion. It boasts more than 100 registered products in Argentina, exports to over 30 countries worldwide, employs over 150 people, and continues to invest in its 6,000-square-meter industrial plant located in Malvinas Argentinas (GBA), certified under Senasa's GMP standards (currently undergoing its fourth recertification). (motivar.com.ar, March).

?? Veterquimica y Ourofino They have launched a new Reproductive Line for Chile. Through specialized talks and the participation of representatives from both companies, along with advisors, professionals, and technicians in the field, the products were introduced in an unprecedented alliance. The products were presented during a session where the genesis of this alliance was discussed, bringing together two major companies to introduce Chile to the Reproductive Line, which was showcased to advisors and professionals in the livestock sector. Attendees had the opportunity to learn about the product's properties, interact with company executives, and enjoy an entertaining session that included raffles and prizes for participants. (diarolechero.cl, March 18th).

?? Zoetis Chile: On Thursday, March 7th, at the Intercontinental Hotel in Santiago de Chile, the official launch of Librela and Solensia took place. The entire Zoetis team participated, and the event reflected the magnitude of a launch associated with these new and innovative therapies for managing pain in canine and feline osteoarthritis (OA). Zoetis is contributing to and supporting veterinary medicine in Chile by providing unique and innovative tools to improve the quality of life for their patients. (LinkedIn, March).

?? Elanco Spain Elanco Animal Health has celebrated the second edition of the technical session on challenges and opportunities in the laying poultry sector, addressing current and relevant topics in the egg industry in Spain. The company's technical team, along with renowned consultants, tackled significant current challenges faced by the sector, such as personnel management and sustainability in laying poultry farming. The event took place from March 12th to 14th in Granada, where discussions were held regarding these important issues. (portalveterinaria.com, March 22th).

?? Boehringer Ingelheim y UNED Boehringer Ingelheim and the National Distance Education University (UNED) have jointly presented the results of the largest study on stress factors in veterinary practice in Spain, during an event held at the Faculty of Education of UNED in Madrid. The event brought together over 1200 veterinarians in a concerted effort to address the importance of mental health in the veterinary profession. The audience included a diverse and committed group, consisting of veterinarians from various specialties and opinion leaders in the field of animal health. (avinews.com, March 22th).

?? Vetoquinol In 2023, the company saw an increase in profits of over 15%. This was attributed to strong sales performance in the second half of the year, contributing to a solid financial structure to support its growth strategy. The Vetoquinol Group has unveiled its financial results for 2023, reporting a net profit of 55.6 million euros, which represents 10.5% of the 2023 sales. This marks a 15.7% increase compared to 2022 figures. Additionally, Vetoquinol's sales for the fiscal year 2023 amounted to 529 million euros, remaining stable at constant exchange rates. The strong sales in the second half of 2023, with a 4.5% increase at constant exchange rates, offset the disruptions experienced in the first half due to cyclical phenomena, particularly currency impacts. (animalshealth.es, March 21th).

?? Elanco Saúde Animal Brasil The "Novos Enfoques 2024" conference discussed health and nutrition for cattle. The company supported the participation of around 300 technical professionals, veterinarians, and animal scientists at the event. Considered one of the main initiatives for scientific updates in the national cattle industry, the event took place on March 21st and 22nd in Uberlandia (MG), sponsored by Elanco as the Master sponsor. Estimates indicate a global increase in animal protein consumption by 90 million metric tons over the next decade, according to data from the global organization World Food Programme (WFP)*. Brazil plays a key role in meeting this demand, essential for addressing food insecurity worldwide. (saladenoticia.com.br, 21th of March).

?? Bergen, Norway, March 18, 2024 – The BU Aqua, in close collaboration with Vaxxinova Autogenous Vaccines GmbH in Cuxhaven, Germany, has launched a video last week. The video dives into the process of the making of an autogenous vaccine. In this case for cold water fish. The production was filmed on site in Norway and Germany. (Vaxxinova site, March 18th).

?? Human and animal generics manufacturer Chanelle Pharma, the largest domestic drugmaker in Ireland, was acquired by U.K. private equity firm Exponent. Although financial details of the deal weren't disclosed, market analysts have previously speculated the maker of both generic human and animal drugs would likely reap around 300 million euros ($323 million), according to the Irish Independent. Chanelle, which is located near Galway, Ireland, was founded almost 40 years ago and employs more than 700 workers in Ireland, the U.K., Europe and Jordan, according to a Feb. 7 press release. (fiercepharma.com, Feb).

www.animalhealthnexus.com

[email protected]

+59899728874